STOCK TITAN

Director at Solventum (SOLV) exercises 1,980 RSUs into common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Solventum Corp director John H. Weiland exercised equity awards rather than trading in the open market. On March 27, 2026, he exercised 1,980 Restricted Stock Units, each converting into one share of Solventum common stock at a stated price of $0.00 per share.

Following this RSU settlement, Weiland now directly holds 5,544 shares of Solventum common stock. The filing shows no open-market purchases or sales, only the conversion of fully vested RSUs into common shares as part of his equity compensation.

Positive

  • None.

Negative

  • None.
Insider WEILAND JOHN H
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Units 1,980 $0.00 --
Exercise Common Stock 1,980 $0.00 --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock — 5,544 shares (Direct)
Footnotes (1)
  1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock Upon settlement. The RSUs are fully vested.
RSUs exercised 1,980 units Restricted Stock Units converted into common stock on March 27, 2026
Common shares received 1,980 shares Shares of Solventum common stock issued upon RSU settlement
Holdings after transaction 5,544 shares Total Solventum common stock directly owned by John H. Weiland after the exercise
Exercise price $0.00 per share Stated transaction price per share for RSU conversion into common stock
Transaction count (acquire) 2 transactions One derivative RSU exercise and one corresponding common stock entry
Restricted Stock Units financial
"Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSU financial
"Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share"
Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Common Stock financial
"Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WEILAND JOHN H

(Last)(First)(Middle)
1750 YANKEE DOODLE ROAD

(Street)
EAGAN MINNESOTA 55121

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Solventum Corp [ SOLV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/27/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/27/2026M1,980A$05,544D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)03/27/2026M1,980 (2)05/13/2034Common Stock1,980$00D
Explanation of Responses:
1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock Upon settlement.
2. The RSUs are fully vested.
Remarks:
/s/Megan Bombick, attorney-in-fact for John H. Weiland03/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Solventum (SOLV) report for John H. Weiland?

Solventum reported that director John H. Weiland exercised 1,980 Restricted Stock Units into common stock on March 27, 2026. This was an equity award conversion, not an open‑market trade, reflecting routine compensation rather than discretionary stock buying or selling.

How many Solventum (SOLV) shares does John H. Weiland hold after this Form 4?

After the RSU exercise, John H. Weiland directly holds 5,544 shares of Solventum common stock. This reflects the addition of 1,980 newly issued shares from fully vested Restricted Stock Units converting into common shares at a stated price of $0.00 per share.

Was the Solventum (SOLV) insider Form 4 an open-market purchase or sale?

The Form 4 does not show any open‑market purchases or sales. Instead, it records the exercise of 1,980 fully vested Restricted Stock Units into common stock, a compensation-related conversion that increases the director’s holdings without signaling discretionary buying or selling activity.

What security types were involved in the Solventum (SOLV) Form 4 filing?

The filing involves Restricted Stock Units and common stock. John H. Weiland exercised 1,980 RSUs, each representing a contingent right to receive one share, resulting in 1,980 Solventum common shares being issued to him upon settlement on March 27, 2026.

Are the Solventum (SOLV) Restricted Stock Units in this filing fully vested?

Yes. The footnotes state that the RSUs are fully vested, meaning the vesting conditions have already been satisfied. As a result, each RSU represented a vested right to receive one share of Solventum common stock upon settlement on March 27, 2026.